104 related articles for article (PubMed ID: 2905241)
21. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
Naccaratto R; Cremer M; Dammann HG; Keohane PP; Mulder H; Sarles H; Simon B
Scand J Gastroenterol Suppl; 1987; 136():71-8. PubMed ID: 2892258
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of acute stomach ulcer with H2 receptor antagonists. A direct therapy comparison with 300 mg nizatidine nightly and 2 times 150 mg nizatidine with twice daily 150 mg ranitidine].
Arnold R; Beckenbach P; Bock H; Bormann R; Brunner G; Daake H; Dammann HG; Dietrich K; Fuerer M; Geiter B
Fortschr Med; 1989 Jun; 107(17):390-4. PubMed ID: 2568327
[TBL] [Abstract][Full Text] [Related]
23. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
[TBL] [Abstract][Full Text] [Related]
24. Effect of roxatidine acetate on daytime and night-time peptone-stimulated gastric acid secretion.
Hagenmüller F
Drugs; 1988; 35 Suppl 3():65-8. PubMed ID: 2905251
[TBL] [Abstract][Full Text] [Related]
25. A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer.
Walt RP; Logan RF; Hawkey CJ; Daneshmend TK; Long RG; Cooper BT; Langman MJ; Collins M; Street R
Aliment Pharmacol Ther; 1991 Jun; 5(3):301-7. PubMed ID: 1679668
[TBL] [Abstract][Full Text] [Related]
26. The use of roxatidine acetate in fasting patients prior to induction of anaesthesia as prophylaxis against the acid aspiration syndrome.
Tryba M; Wruck G; Thole H; Zenz M
Drugs; 1988; 35 Suppl 3():20-4. PubMed ID: 2905245
[TBL] [Abstract][Full Text] [Related]
27. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
[TBL] [Abstract][Full Text] [Related]
28. Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience.
Simon B; Müller P; Dammann HG
J Clin Gastroenterol; 1987; 9 Suppl 2():19-22. PubMed ID: 2887614
[TBL] [Abstract][Full Text] [Related]
29. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134
[TBL] [Abstract][Full Text] [Related]
30. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study.
Paoluzi P; Torsoli A; Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Carratelli L; Cheli R
Digestion; 1985; 32 Suppl 1():38-44. PubMed ID: 2866135
[TBL] [Abstract][Full Text] [Related]
31. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
[TBL] [Abstract][Full Text] [Related]
32. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
Hemery P; Congard P; Galmiche JP; Bonfils S
Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
[TBL] [Abstract][Full Text] [Related]
33. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
[TBL] [Abstract][Full Text] [Related]
34. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.
Deakin M; Williams JG
Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563
[TBL] [Abstract][Full Text] [Related]
35. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
[TBL] [Abstract][Full Text] [Related]
36. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
[TBL] [Abstract][Full Text] [Related]
37. [Circadian aspects of diclofenac gastroduodenopathy and the protective effect of roxatidine].
Müller P; Jackisch P; Simon B
Z Rheumatol; 1993; 52(5):297-300. PubMed ID: 7903132
[TBL] [Abstract][Full Text] [Related]
38. A single-centre study of gastric ulcer healing with 300 mg ranitidine at night versus 150 mg ranitidine twice daily.
Jorde R; Burhol PG
Scand J Gastroenterol; 1986 Sep; 21(7):833-6. PubMed ID: 3535010
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of gastric ulcer with ranitidine: comparison of a single 300 mg dose at night with 150 mg twice a day].
Massuda HK; Bettarello A; Eisig JN; Chinzon D; Zaterka S
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):181-4. PubMed ID: 2700102
[TBL] [Abstract][Full Text] [Related]
40. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
